Insider · CIK 0001569225

Castelli Jeff

Reports to the SEC for 1 company · PRINCETON, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001569225

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-04-27	AMICUS THERAPEUTICS, INC.D Disposition to Issuer	Chief Development Officer	DDisposition to Issuer	−427K sh	$14.50	−$6.19M	0
2026-04-27	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)D Disposition to Issuer	Chief Development Officer	DDisposition to Issuer	−82.6K sh	—	—	0
2026-04-27	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)D Disposition to Issuer	Chief Development Officer	DDisposition to Issuer	−108K sh	—	—	0
2026-04-27	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)D Disposition to Issuer	Chief Development Officer	DDisposition to Issuer	−108K sh	—	—	0
2026-04-27	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)D Disposition to Issuer	Chief Development Officer	DDisposition to Issuer	−125K sh	—	—	0
2026-04-27	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)D Disposition to Issuer	Chief Development Officer	DDisposition to Issuer	−99.1K sh	—	—	0
2026-04-27	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)D Disposition to Issuer	Chief Development Officer	DDisposition to Issuer	−151K sh	—	—	0
2026-01-03	AMICUS THERAPEUTICS, INC.F Tax Payment	Chief Development Officer	FTax Payment	−23.1K sh	$14.27	−$330K	409,311
2026-01-02	AMICUS THERAPEUTICS, INC.F Tax Payment	Chief Development Officer	FTax Payment	−6,905 sh	$14.27	−$98.5K	432,413
2025-11-24	AMICUS THERAPEUTICS, INC.M Exercise/Conversion	Chief Development Officer	MExercise/Conversion	+50K sh	$9.03	+$451K	515,476
2025-11-24	AMICUS THERAPEUTICS, INC.S Sale	Chief Development Officer	SSale	−76.2K sh	$10.16	−$774K	439,318
2025-11-24	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)M Exercise/Conversion	Chief Development Officer	MExercise/Conversion	−50K sh	—	—	0
2025-02-11	AMICUS THERAPEUTICS, INC.A Award	Chief Development Officer	AAward	+52.3K sh	—	—	488,200
2025-02-11	AMICUS THERAPEUTICS, INC.F Tax Payment	Chief Development Officer	FTax Payment	−22.7K sh	$9.57	−$217K	465,476
2025-01-04	AMICUS THERAPEUTICS, INC.F Tax Payment	Chief Development Officer	FTax Payment	−3,127 sh	$9.41	−$29.4K	435,862
2025-01-03	AMICUS THERAPEUTICS, INC.A Award	Chief Development Officer	AAward	+83.1K sh	—	—	453,288
2025-01-03	AMICUS THERAPEUTICS, INC.F Tax Payment	Chief Development Officer	FTax Payment	−14.3K sh	$9.41	−$135K	438,989
2025-01-03	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)A Award	Chief Development Officer	AAward	+151K sh	—	—	150,517
2025-01-02	AMICUS THERAPEUTICS, INC.F Tax Payment	Chief Development Officer	FTax Payment	−6,990 sh	$9.31	−$65.1K	370,215
2024-01-09	AMICUS THERAPEUTICS, INC.F Tax Payment	Chief Development Officer	FTax Payment	−10K sh	$13.65	−$137K	362,800
2024-01-09	AMICUS THERAPEUTICS, INC.A Award	Chief Development Officer	AAward	+14.4K sh	—	—	387,210
2024-01-09	AMICUS THERAPEUTICS, INC.F Tax Payment	Chief Development Officer	FTax Payment	−10K sh	$13.65	−$137K	377,205
2024-01-04	AMICUS THERAPEUTICS, INC.F Tax Payment	Chief Development Officer	FTax Payment	−3,127 sh	$13.44	−$42K	372,805
2024-01-03	AMICUS THERAPEUTICS, INC.F Tax Payment	Chief Development Officer	FTax Payment	−14.1K sh	$13.53	−$191K	375,932
2024-01-02	AMICUS THERAPEUTICS, INC.A Award	Chief Development Officer	AAward	+57.4K sh	—	—	398,053
2024-01-02	AMICUS THERAPEUTICS, INC.F Tax Payment	Chief Development Officer	FTax Payment	−8,038 sh	$14.24	−$114K	390,015
2024-01-02	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)A Award	Chief Development Officer	AAward	+99.1K sh	—	—	99,073
2023-12-28	AMICUS THERAPEUTICS, INC.S Sale	Chief Development Officer	SSale	−17.4K sh	$14.52	−$253K	340,661
2023-12-20	AMICUS THERAPEUTICS, INC.S Sale	Chief Development Officer	SSale	−1,654 sh	$13.10	−$21.7K	358,082
2023-12-19	AMICUS THERAPEUTICS, INC.S Sale	Chief Development Officer	SSale	−17.5K sh	$13.25	−$232K	359,736
2023-12-18	AMICUS THERAPEUTICS, INC.A Award	Chief Development Officer	AAward	+8,643 sh	—	—	377,236
2023-08-17	AMICUS THERAPEUTICS, INC.F Tax Payment	Chief Development Officer	FTax Payment	−14.6K sh	$12.77	−$186K	368,593
2023-01-11	AMICUS THERAPEUTICS, INC.A Award	Chief Development Officer	AAward	+56K sh	—	—	407,478
2023-01-11	AMICUS THERAPEUTICS, INC.F Tax Payment	Chief Development Officer	FTax Payment	−24.3K sh	$12.02	−$292K	383,153
2023-01-04	AMICUS THERAPEUTICS, INC.F Tax Payment	Chief Development Officer	FTax Payment	−3,127 sh	$12.03	−$37.6K	351,454
2023-01-03	AMICUS THERAPEUTICS, INC.A Award	Chief Development Officer	AAward	+70.7K sh	—	—	360,992
2023-01-03	AMICUS THERAPEUTICS, INC.F Tax Payment	Chief Development Officer	FTax Payment	−6,411 sh	$11.93	−$76.5K	354,581
2023-01-03	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)A Award	Chief Development Officer	AAward	+125K sh	—	—	125,462
2023-01-02	AMICUS THERAPEUTICS, INC.F Tax Payment	Chief Development Officer	FTax Payment	−13.9K sh	$12.21	−$170K	290,311
2015-06-22	AMICUS THERAPEUTICS, INC.M Exercise/Conversion	Chief Development Officer	MExercise/Conversion	+19K sh	$13.94	+$265K	43,981
2015-06-22	AMICUS THERAPEUTICS, INC.S Sale	Chief Development Officer	SSale	−19K sh	$13.94	−$265K	25,000
2015-06-22	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)M Exercise/Conversion	Chief Development Officer	MExercise/Conversion	−1,944 sh	—	—	19,562
2015-06-22	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)M Exercise/Conversion	Chief Development Officer	MExercise/Conversion	−6,264 sh	—	—	17,502
2015-06-22	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)M Exercise/Conversion	Chief Development Officer	MExercise/Conversion	−10.8K sh	—	—	7,297
2015-06-15	AMICUS THERAPEUTICS, INC.S Sale	Chief Development Officer	SSale	−7,377 sh	$14.17	−$105K	0
2015-06-08	AMICUS THERAPEUTICS, INC.M Exercise/Conversion	Chief Development Officer	MExercise/Conversion	+17.3K sh	$12.87	+$223K	42,312
2015-06-08	AMICUS THERAPEUTICS, INC.S Sale	Chief Development Officer	SSale	−17.3K sh	$12.87	−$223K	25,000
2015-06-08	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)M Exercise/Conversion	Chief Development Officer	MExercise/Conversion	−2,314 sh	—	—	21,506
2015-06-08	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)M Exercise/Conversion	Chief Development Officer	MExercise/Conversion	−15K sh	—	—	30,002
2015-06-01	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)A Award	Chief Development Officer	AAward	+50K sh	—	—	50,000

Recent filings

Accepted (ET)
Apr 274
Castelli Jeff0001193125-26-182257
SEC(opens sec.gov)
Jan 64
Castelli Jeff0001193125-26-005047
SEC(opens sec.gov)
Nov 264
Castelli Jeff0001193125-25-301021
SEC(opens sec.gov)
Feb 134
Castelli Jeff0000950170-25-020039
SEC(opens sec.gov)
Jan 64
Castelli Jeff0000950170-25-002424
SEC(opens sec.gov)
Mar 154/A
Castelli Jeff0000950170-24-032404
SEC(opens sec.gov)

Companies

AMICUS THERAPEUTICS, INC.Chief Development Officer

Address

47 HULFISH STREET

PRINCETON, NJ, 08542